Salus BioMed
PrivateLast Round
Series B
Oct 10, 2025
Total Funding Raised
$20.92M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Salus BioMed operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series B round in October 2025.
Salus BioMed is a life sciences company that provides a DNA sequencing platform and develops high-definition spatial transcriptomics to measure gene activity, aiding in the diagnosis and treatment of diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salus BioMed Comparables
Compare Salus BioMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneMind Biosciences Co., Ltd. | 88% | |
| Qitan Tech | 84% | |
| Axbio | 78% |
For institutional investors. Book with your work email.
Salus BioMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 10, 2025 | ||||
| Series A Extension | May 14, 2025 | ||||
| Series A | Dec 1, 2023 | ||||
| Seed | Oct 18, 2022 | ||||
| Angel | Oct 1, 2021 |
For institutional investors. Book with your work email.
Salus BioMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A |
| ZhenFund | Angel |
| 苏州敦行投资管理有限公司 | Series A |
| Qianhai Ark Asset Management | Series A |
| Shenzhen Capital Group | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 791% MoM to 3.8K.
- Aug 20, 2026
Monthly visitors grew 849% MoM, from 45 to 427.
For institutional investors. Book with your work email.
Salus BioMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Salus BioMed's valuation, stock price, and market status.
Is Salus BioMed a public or private company?
Salus BioMed is a private company.
What is the current stock price of Salus BioMed?
Salus BioMed is a private company, so its shares have no public market price. Caplight tracks Salus BioMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Salus BioMed worth (valuation)?
Valuation information for Salus BioMed is not publicly available.
Can I buy Salus BioMed stock?
Salus BioMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Salus BioMed's last funding round?
Salus BioMed's most recent funding round was Series B on October 10, 2025.
Who are the main investors in Salus BioMed?
Key investors in Salus BioMed include BioTrack Capital, ZhenFund, Qianhai Ark Asset Management, Shenzhen Capital Group.
Will Salus BioMed IPO soon?
No public IPO plans have been announced for Salus BioMed.
How can I track Salus BioMed secondary market activity?
Caplight tracks bids, offers, and trades in Salus BioMed's shares on secondary markets.